Primary tabs

Perspectives

Accelerated approval of anticancer drugs: a safe choice?

All oncologists know how anxiously cancer patients look forward to the availability in clinical practice of drugs that have yielded positive results in the registration trials.

[more]
Archive

Focus on

Medication review and deprescribing: from theory to implementation in different care settings
Medication review and deprescribingThe increase in life expectancy and the growing availability of effective drugs for the management of chronic diseases are leading to an increase in the number of patients, suffering of multimorbidity, in polypharmacotherapy (regular intake of at least five...
[more]
Archive

Columns

Drugs & Elderly
Safety of drugs in the elderly population in Italy
In recent years, the concept of deprescribing has been introduced, based on the reduction of the number of drugs taken in order to optimize the risk-benefit ratio of polypharmacy taking into account the goals of treatment and the preferences of the patient; however, the available intervention...
[more]
Archive

From regulatory agencies

12 September 2024 FDA
FDA Adds Warning About Rare Occurrence of Serious Liver Injury with Use of Veozah (fezolinetant) for Hot Flashes Due to Menopause. Stop Medicine if Signs and Symptoms of Liver Injury Occur - Drug Safety Communication
12 September 2024 CADTH
téprotumumab
12 September 2024 CADTH
téprotumumab
11 September 2024 CADTH
Le méthoxyflurane inhalé comme analgésique dans les interventions mineures gynécologiques, ambulatoires ou urgentes
09 September 2024 CADTH
Les pénuries de médicaments et leurs préjudices pour les patients
06 September 2024 CADTH
blinatumomab
06 September 2024 CADTH
bimékizumab
06 September 2024 FDA
Related Recalls - Plastic Syringes Made in China for Potential Device Failures
05 September 2024 CADTH
guselkumab
05 September 2024 CADTH
ruxolitinib
Link 
80.211.154.110